Activation of the NLRP3 inflammasome increases the IL-1 level and decreases GLUT4 translocation in skeletal muscle during insulin resistance
However, desensitization can be preferred if alternative GLP-1 receptor analogues are not available
Note, the recent ESC guidelines recommending SGLT2i and GLP-1RA therapy do so irrespective of background metformin therapy
As a triple-receptor agonist acting on GLP-1, GIP, and glucagon receptors, retatrutide uniquely interacts with hepatic and adipose glucagon pathways responsible for regulating glucose turnover, lipid metabolism, and overall energy balance
The integration of all three pathways is hypothesized to produce synergistic metabolic effects greater than any single or dual agonist combination
Ive owned this set for a year, and I love how versatile it is